전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
cholestyramine
kolestiramīns
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
cholestyramine and colestipol resins
holestiramīns un žultsskābi saistoši sveķi
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
cholestyramine and colestipol resins:
23 holestiramīns un holestipola sveķi:
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
cholestyramine (used to treat high cholesterol)
kolestiramīns (zāles, ko lieto augsta holesterīna līmeņa ārstēšanai);
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
cholestyramine may potentially reduce canagliflozin exposure.
kolestiramīns var iespējami mazināt kanagliflozīna kopējo iedarbību.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
accelerated elimination procedure: cholestyramine and activated charcoal
paātrinātas izvadīšanas procedūra: kolestiramīns un aktivētā ogle
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
cholestyramine and colestipol, medicines for lowering blood fat levels.
holestiramīns un kolestipols, zāles tauku līmeņa asinīs samazināšanai.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
the recommended elimination procedure is cholestyramine 8 g three times a day for 11 days.
ieteicamā izvadīšanas procedūra ir 8 g kolestiramīna trīsreiz dienā 11 dienas.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
absorption of thiazide diuretics, including hydrochlorothiazide, is decreased by cholestyramine or colestipol.
holestiramīns un kolestipols samazina tiazīdu grupas diurētisko līdzekļu, tai skaitā arī hidrohlortiazīda, uzsūkšanos.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
if this is not well tolerated, cholestyramine 4 g three times a day for 11 days can be used.
ja panesība nav laba, var lietot 4 g kolestiramīna trīsreiz dienā 11 dienas.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
due to the prolonged half-life, accelerated elimination with cholestyramine or charcoal may be considered.
pagarinātā eliminācijas pusperioda dēļ var apsvērt paātrinātu izvadīšanu ar kolestiramīnu vai aktivēto ogli.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
tell your doctor if you are taking cholestyramine which is mainly used as lipid-lowering medicine.
pastāstiet savam ārstam, ja lietojat holestiramīnu, kuru lieto galvenokārt lipīdu līmeņa pazemināšanai.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
alternatively, when cholestyramine is not available, activated charcoal 50 g twice a day for 11 days may also be used.
ja kolestiramīns nav pieejams, var lietot arī 50 g aktivētās ogles divreiz dienā 11 dienas.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
co-administration of cholestyramine or colestipol with propranolol resulted in up to 50% decrease in propranolol concentrations.
holestiramīna un kolestipola vienlaicīga lietošana ar propranololu līdz 50% samazināja propranolola koncentrāciju.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
cholestyramine, colestipol or other resins (substances used mainly to treat high levels of lipids in the blood);
kolestiramīnu, kolestipolu vai citiem sveķiem (savienojumus, ko lieto galvenokārt paaugstināta lipīdu līmeņa ārstēšanai asinīs);
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
cholestyramine, colestipol or other resins (substances used mainly to treat high levels of lipids in the blood).
holestiramīnu, kolestipolu vai citus sveķus (savienojumus, ko lieto galvenokārt paaugstināta lipīdu līmeņa ārstēšanai asinīs);
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
tell your doctor if you are taking cholestyramine which is mainly used as lipid-lowering medicine, because evista may not work as well.
pastāstiet savam ārstam, ja lietojat holestiramīnu, kuru lieto galvenokārt lipīdu līmeņa pazemināšanai, jo tas var mazināt evista iedarbības efektivitāti.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
after the rapid elimination procedure with cholestyramine, an additional 23.1% was recovered (mostly in feces).
pēc straujas izvadīšanas procedūras ar kolestiramīnu tika izvadīti vēl 23,1 % lietotās devas (galvenokārt fēcēs).
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
by interfering with enterohepatic circulation of the drug, bile acid sequestrants such as cholestyramine, reduce mpa auc (see section 4.9).
ietekmējot zāļu enterohepātisko cirkulāciju, žultsskābju sekvestranti, piemēram, kolestiramīns, samazina mfs auc (skatīt 4.9. apakšpunktu).
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
by interfering with enterohepatic circulation of the medicinal product, bile acid sequestrants such as cholestyramine, reduce mpa auc (see section 4.9).
ietekmējot zāļu enterohepātisko cirkulāciju, žultsskābju sekvestranti, piemēram, kolestiramīns, samazina mpa auc (skatīt 4.9. apakšpunktu).
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질: